Price $77.32 |
Market Cap
10.83B
|
Sector Health Care |
Div. Growth
12.50%
|
|
P/E
37.9
|
P/B
11.89
|
P/S
4.4
|
Dividend %
0.30%
|
|
P/CF
103.7
|
P/FCF
133.3
|
Op. Cash Flow
195.9K
|
FCF
0.5
|
|
Op. Margin
16.20%
|
Net Margin
10.80%
|
ROE
27.40%
|
ROI
12.50%
|
|
ROA
7.90%
|
EPS Growth
2.10%
|
Current Ratio
2.6
|
Debt/Equity
114.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cytosorbents Corp (CTSO) | $3.41 | - | - | 136.1M | Strong Buy |
| Baudax Bio Inc (BXRX) | $1.70 | - | - | 4.8M | Strong Buy |
| Sesen Bio Inc (SESN) | $0.63 | - | - | 118.9M | Strong Buy |
| Shineco Inc (SISI) | $0.60 | - | - | 15.9M | Strong Buy |
| Dare Bioscience Inc (DARE) | $1.04 | - | - | 95M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
